Medy-Tox KRX:086900KOSDAQ

메디톡스 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days8
DART filings, 7 days1
Articles tracked124since Sep 11

In Q2 2026, Medy-Tox reported revenue of ₩68.7bn, up 11.4% year on year, and operating profit of ₩4.8bn. Medy-Tox (메디톡스) appeared in 8 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 19 with 20 articles. The most common catalyst was risk & warnings (1). It was most often mentioned alongside 글로벌테크놀로지, Hugel and Daewoong Pharma.

Medy-Tox quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩68.7bn+11.4%₩4.8bn
margin 6.9%
₩3.1bn
Q1 2026₩60.7bn-5.1%₩7.4bn
margin 12.1%
₩7.9bn
Q4 2025 derived₩60.7bn+10.0%−₩3.7bn
margin −6.1%
−₩3.1bn
Q3 2025₩61.0bn+13.3%₩8.9bn
margin 14.6%
₩7.2bn
Q2 2025₩61.6bn-5.2%₩6.3bn
margin 10.2%
₩8.2bn
Q1 2025₩64.0bn+17.2%₩5.5bn
margin 8.6%
₩3.3bn
Q4 2024 derived₩55.2bn-18.9%₩947m
margin 1.7%
₩2.4bn
Q3 2024₩53.9bn-8.2%₩6.0bn
margin 11.1%
₩3.8bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Medy-Tox top stories 2 weeks, by number of outlets

  1. 1
    메디톡스, 21개국 의료진 초청 글로벌 심포지엄 개최
    5 outlets · 5 articlesFirst report Oct 21 10:20 핀포인트뉴스글로벌테크놀로지
  2. 2
    메디톡스, 'ICLAS 서울'서 보툴리눔 톡신·필러 임상경험 공유
    3 outlets · 3 articlesFirst report Oct 19 11:34 뉴데일리경제
  3. 3
    메디톡스, 대한비만미용학회 추계학술대회 참가
    3 outlets · 3 articlesFirst report Oct 19 16:12 메디포뉴스
  4. 4
    메디톡스, 'ICLAS 2026' 참가…네트워크 강화 총력
    3 outlets · 3 articlesFirst report Oct 19 11:16 핀포인트뉴스
  5. 5
    메디톡스, 해외 의료진 대상 학술 세미나 개최
    2 outlets · 2 articlesFirst report Oct 23 15:02 라이센스뉴스
  6. 6

Latest Medy-Tox news Korean headlines